Sertraline, a selective inhibitor of serotonin uptake, for the treatment of outpatients with major depressive disorder.
Reimherr
F W
FW
Byerley
W F
WF
Ward
M F
MF
Lebegue
B J
BJ
Wender
P H
PH
D015057:1-Naphthylamine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003866:Depressive Disorder / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009281:Naphthalenes / Q000627:therapeutic use*; D010045:Outpatients; D011897:Random Allocation; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D020280:Sertraline
D009281:Naphthalenes; D012702:Serotonin Antagonists; D015057:1-Naphthylamine; D020280:Sertraline